NEW YORK (GenomeWeb News) – Sequenom today said that increased sales of its MassArray system and consumables drove a 25-percent increase in second-quarter revenues to $12.8 million from $10.2 million in the second quarter of 2007.
Harry Stylli, president and CEO of Sequenom, said in a conference call to discuss the company’s financial results that the firm placed around 16 MassArray systems during the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.